Effects of continuous localized infusion of granulocyte-macrophage colony-stimulating factor and inoculations of irradiated glioma cells on tumor regression

Journal of Neurosurgery

Volumn 90, Issue 6, 1999, Pages 1064-1071

  Wallenfriedman, Margaret A ^a   Conrad, John A ^a   DelaBarre, Lance ^a   Graupman, Patrick C ^a   Lee, Gina ^a   Garwood, Michael ^a   Gregerson, Dale S ^a   Jean, Walter C ^a   Hall, Walter A ^a   Low, Walter C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Central nervous system tumor; Glioblastoma multiforme; Granulocyte macrophage colony stimulating factor; Immunotherapy; Rat; Vaccine

Indexed keywords

RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FEMALE; GLIOBLASTOMA; GLIOSARCOMA; IMMUNOSTIMULATION; IRRADIATION; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR REGRESSION;

EID: 0032971521     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1999.90.6.1064     Document Type: Article

References (43)

1. Abe J, Wakimoto H, Nakamura Y, et al: Immunogene therapy for cancer by cytokine-gene-modified tumor vaccine and tumor-infiltrating lymphocytes (TIL). Cancer Gene Ther 1:312, 1994
2. Ausiello CM, Maleci A, Cassone A: Modulation of immune function by glioma. Immunol Today 13:148, 1992 (Letter)
3. Colombo MP, Ferrari G, Stoppacciaro A, et al: Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J Exp Med 173: 889-897, 1991
4. Cox DJ, Pilkington GJ, Lantos PL: The fine structure of blood vessels in ethylnitrosourea-induced tumours of the rat nervous system. With special reference to the breakdown of the blood-brain barrier. Br J Exp Pathol 57:419-430, 1976
5. Cserr HF, DePasquale M, Harling-Berg CJ, et al: Afferent and efferent arms of the humoral immune response to CSF-administered albumins in a rat model with normal blood-brain barrier permeability. J Neuroimmunol 40:195-202, 1992
6. Cserr HF, Harling-Berg CJ, Knopf PM, et al: Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain Pathol 2:269-276, 1992
7. Deen DF, Chiarodo A, Grimm EA, et al: Brain tumor working group report on the 9th International Conference on Brain Tumor Research and Therapy. Organ System Program, National Cancer Institute. J Neurooncol 16:243-272, 1993
8. Dranoff G, Jaffee E, Lazenby A, et al: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539-3543, 1993
9. Elliott LH, Brooks WH, Roszman TL: Activation of immunoregulatory lymphocytes obtained from patients with malignant gliomas. J Neurosurg 67:231-236, 1987
10. Elliott LH, Brooks WH, Roszman TL: Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin-2 receptors. J Clin Invest 86:80-86, 1990
11. Fontana A, Hengartner H, de Tribolet N, et al: Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol 132:1837-1844, 1984
12. Fox FE, Capocasale RS, Ford HC, et al: Transforming growth factor-beta inhibits human T-cell proliferation through multiple targets. Lymphokine Cytokine Res 11:299-305, 1992
13. Frei K, Malipiero U, Piani D, et al: Microglia and tumor rejection. Neuropathol Appl Neurobiol 20:206-207, 1994
14. Grabstein KH, Urdal DL, Tushinski RJ, et al: Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science 232:506-508, 1986
15. Graeber MB, Streit WJ: Microglia: immune network in the CNS. Brain Pathol 1:2-5, 1990
16. Heufler C, Koch F, Schuler G: Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 167:700-705, 1988
17. Hickey WF, Hsu BL, Kimuta H, et al: T-lymphocyte entry into the central nervous system. J Neurosci Res 28:254-260, 1991
18. Inaba K, Inaba M, Romani N, et al: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693-1702, 1992
19. 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma. J Neurosurg 78:944-951, 1993
20. Jean WC, Spellman SR, Wallenfriedman MA, et al: Interleukin-12-based immunotherapy against rat 9L glioma. Neurosurgery 42:850-857, 1998
21. Lampson LA, Hickey WF: Monoclonal antibody analysis of MHC expression in human brain biopsies: tissue ranging from 'histologically normal' to that showing different levels of glial tumor involvement. J Immunol 136:4054-4062, 1986
22. Kämpgen E, Koch F, Heufler C, et al: Understanding the dendritic cell lineage through a study of cytokine receptors. J Exp Med 179:1767-1776, 1994
23. Levin VA, Gutin PM, Leibel S: Neoplasms of the central nervous system, in DeVita VT, Kellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. Philadelphia: JB Lippincott, 1993, pp 1679-1737
24. Mahaley MS Jr, Mettlin C, Natarajan N: National survey of patterns of care for brain-tumor patients. J Neurosurg 71: 826-836, 1989
25. Markowicz S, Engleman EG: Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. J Clin Invest 85: 955-961, 1990
26. Morioka T, Baba T, Black KL, et al: Immunophenotypic analysis of infiltrating leucocytes and microglia in an experimental rat glioma. Acta Neuropathol 83:590-597, 1992
27. Morioka T, Baba T, Black KL, et al: Inflammatory cell infiltrates vary in experimental primary and metastatic brain tumors. Neurosurgery 30:891-896, 1992
28. Myers RL, Whisler RL, Stephens RE, et al: Sensitivity of human glioma and brain cells to natural killer cell lysis. Effects of serum concentration, epidermal growth factor, and tissue in culture. J Neurosurg 76:986-990, 1992
29. Paglia P, Girolomoni G, Robbiati F, et al: Immortalized dendritic cell line fully competent in antigen presentation initiates primary T cell responses in vivo. J Exp Med 178:1893-1901, 1993
30. Parney IF, Petruk KC, Zhang C, et al: Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model. Hum Gene Ther 8: 1073-1085, 1997
31. Roszman T, Elliott I, Brooks W: Modulation of T-cell function by gliomas. Immunol Today 12:370-374, 1991
32. Sanda MG, Ayyagari SR, Jaffee EM, et al: Demonstration of a rational strategy for human prostate cancer gene therapy. J Urol 151:622-628, 1994
33. 1H MRS. Magn Reson Med 30:18-27, 1993
34. Schwyzer M, Fontana A: Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells. J Immunol 134:1003-1009, 1985
35. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271-296, 1991
36. Tada M, de Tribolet N: Recent advances in immunobiology of brain tumors. J Neurooncol 17:261-271, 1993
37. Tazi A, Bouchonnet F, Grandsaigne M, et al: Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J Clin Invest 91:566-576, 1993
38. Tzeng JJ, Barth RF, Orosz CG, et al: Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors. Cancer Res 51:2373-2378, 1991
39. Unger ER, Sung JH, Manivel JC, et al: Male donor-derived cells in the brains of female sex-mismatched bone marrow transplant recipients: a Y-chromosome specific in situ hybridization study. J Neuropathol Exp Neurol 52:460-470, 1993
40. Urbani F, Maleci A, La Sala A, et al: Defective expression of interferon-γ, granulocyte-macrophage colony-stimulating factor, tumor necrosis factor α, and interleukin-6 in activated peripheral blood lymphocytes from glioma patients. J Interferon Cytokine Res 15:421-429, 1995
41. Wells J, Vietje BP, Wells DG, et al: Repair of the blood-brain barrier during the first week after septo-hippocampal transplants. Proc Soc Neurosci 13:287, 1987 (Abstract)
42. Wen PY, Lampson MA, Lampson LA: Effects of γ-interferon on major histocompatibility complex antigen expression and lymphocytic infiltration in the 9L gliosarcoma brain tumor model: implications for strategies of immunotherapy. J Neuroimmunol 36:57-68, 1992
43. Witmer-Pack MD, Olivier W, Valinsky J, et al: Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med 166:1484-1498, 1987